Business description
AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
Management board & Supervisory board
| CEO |
| Pascal Soriot |
| Management board |
| Aradhana Sarin, David Fredrickson, Iskra Reic, Jeff Pott, Katarina Ageborg, Leon Wang, Menelas Pangalos, Pam Cheng, Ruud Dobber, Susan Galbraith |
| Supervisory board |
| Leif Johannson, Andreas Rummelt, Deborah DiSanzo, Diana Layfield, Euan Ashley, Marc Dunoyer, Marcus Wallenberg, Michel Demaré, Nazneen Rahman, Pascal Soriot, Philip Broadley, Sheri McCoy, Tony Mok |
Company data
| Name: |
AstraZeneca plc |
| Address: |
2 Kingdom Street,UK-London W2 6BD |
| Phone: |
+44-20-7604-8000 |
| Fax: |
+44-20-7604-8151 |
| E-mail: |
-
|
| Internet: |
www.astrazeneca.com |
| Industry: |
Healthcare |
| Sector: |
Pharmaceutical Industry |
| Sub sector: |
Pharmaceuticals |
| End of financial year: |
12/31 |
| Free Float: |
73.60% |
| IPO date: |
- |
Investor relations
| Name: |
Thomas Kudsk Larsen |
| IR phone: |
+44-203-749-5712 |
| IR Fax: |
- |
| IR e-mail: |
IR@astrazeneca.com
|